Philip J. Bergman, DVM, MS, PhD, DACVIM/Oncology, Veterinary Specialist
Philip J. Bergman, DVM, MS ,PhD, DACVIM (Oncology)
Director, Clinical Studies, VCA
Dr. Bergman is the Director of Clinical Studies for VCA. He is the principal veterinary investigator for the recently fully licensed canine melanoma vaccine (Oncept). Dr. Bergman is an adjunct faculty member of the Memorial Sloan-Kettering Cancer Center. Prior to Dr. Bergman joining VCA, he served as the Chief Medical Officer for BrightHeart Veterinary Centers from July 2007 to August 2011; from 1999 to June 2007 he was the head of the Donaldson-Atwood Cancer Center at AMC. After finishing veterinary school from Colorado State in 1990, he was an intern at Kansas State (90-91) and returned to CSU for his medical oncology residency (91-94) and then completed a PhD Fellowship in human cancer biology from the M.D. Anderson Cancer Center in Houston (94-99). He was previously Chair of the ACVIM Board of Regents and President of the Veterinary Cancer Society.
Dr. Bergman has been an veterinary oncologist at Katonah Bedford Veterinary Center since 2007.